Home › Focal Segmental Glomerulosclerosis › Texas › Houston
Focal Segmental Glomerulosclerosis clinical trials in Houston, TX
5 studies for Focal Segmental Glomerulosclerosis are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
RecruitingPhase 2
- Investigator Site #18, Houston
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
RecruitingPhase 3
- Provecta Researh Network, Houston
- Provecta Research Path Forward Ventures, Humble · 17 mi away
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
RecruitingPhase 2
- Prolato Clinical Research Center- Site Number : 8400016, Houston
Nephrotic Syndrome Study Network
RecruitingObservational study
- Texas Children's Hospital - Baylor College of Medicine, Houston
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
RecruitingPhase 2
- Texas Children's Hospital, Houston
Focal Segmental Glomerulosclerosis trials in other cities
- Philadelphia, PA9 studies
- Durham, NC8 studies
- New York City, NY7 studies
- Ann Arbor, MI6 studies
- Miami, FL6 studies
- Los Angeles, CA6 studies
- Queens, NY6 studies
- Atlanta, GA5 studies
- Cleveland, OH4 studies
- Chicago, IL4 studies
- Dallas, TX4 studies
- Kansas City, MO4 studies
Other studies in Houston
- Non-Small Cell Lung Cancer145 studies
- Breast Cancer126 studies
- Cancer (all types)121 studies
- Metastatic Cancer104 studies
- Colorectal Cancer102 studies
- Ovarian Cancer89 studies
- Acute Myeloid Leukemia85 studies
- Lung Cancer78 studies
- Prostate Cancer76 studies
- Endometrial Cancer68 studies
- Pancreatic Cancer61 studies
- Melanoma59 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.